Oramed Completes Over 50% Randomization in Its Pivotal 90-Day Clinical Study

Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it has successfully randomized more than 50% of the expected 285 patients for its 90-day dose-ranging Pivo https://www.gurufocus.com/news/769913/oramed-completes-over-50-randomization-in-its-pivotal-90day-clinical-study